Bayer Aktiengesellschaft (BUD:BAYER)

Market Cap	10.53T
Revenue (ttm)	18.45T
Net Income (ttm)	-1,365.55B
Shares Out	n/a
EPS (ttm)	-1,390.32
PE Ratio	n/a
Forward PE	5.88
Dividend	44.63 (0.42%)
Ex-Dividend Date	Apr 28, 2025

Volume	293
Average Volume	117
Open	10,670
Previous Close	n/a
Day's Range	10,670 - 10,700
52-Week Range	7,500 - 11,700
Beta	n/a
RSI	46.09
Earnings Date	Nov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 91,864
• Stock Exchange: Budapest Stock Exchange
• Ticker Symbol: BAYER

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR